Log In
Print this Print this

AML1 / ETO t(8;21)

  Manage Alerts
Collapse Summary General Information
Company Quest Diagnostics Inc.
DescriptionQuantitative real-time PCR
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDaignose acute myeloid leukemia (AML)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today